CrowdStrike (CRWD) Stock Forecast & Price Target

$440.58 +8.70 (+2.01%)

Closing price 05/2/2025 04:00 PM Eastern

Extended Trading

$440.64 +0.06 (+0.01%)

As of 05/2/2025 07:59 PM Eastern

CrowdStrike - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 45 Analyst Ratings

Sell
2

Hold
10

Buy
33

Based on 45 Wall Street analysts who have issued ratings for CrowdStrike in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 45 analysts, 2 have given a sell rating, 10 have given a hold rating, 30 have given a buy rating, and 3 have given a strong buy rating for CRWD.

Consensus Price Target

$400.76
-9.04% Downside

According to the 45 analysts' twelve-month price targets for CrowdStrike, the average price target is $400.76. The highest price target for CRWD is $475.00, while the lowest price target for CRWD is $275.00. The average price target represents a forecasted downside of -9.04% from the current price of $440.58.

Get the Latest News and Ratings for CRWD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CrowdStrike and its competitors.

CRWD Analyst Ratings Over Time

Type	Current Forecast 5/5/24 to 5/5/25	1 Month Ago 4/5/24 to 4/5/25	3 Months Ago 2/5/24 to 2/4/25	1 Year Ago 5/6/23 to 5/5/24
Strong Buy	3 Strong Buy rating(s)	2 Strong Buy rating(s)	3 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	30 Buy rating(s)	30 Buy rating(s)	29 Buy rating(s)	37 Buy rating(s)
Hold	10 Hold rating(s)	10 Hold rating(s)	11 Hold rating(s)	1 Hold rating(s)
Sell	2 Sell rating(s)	2 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$400.76	$400.88	$370.00	$371.87
Forecasted Upside	-9.04% Downside	24.64% Upside	-9.21% Downside	19.88% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CRWD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRWD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

CrowdStrike Stock vs. The Competition

Type	CrowdStrike	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.76	2.66	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	-9.04% Downside	130.70% Upside	17.54% Upside
News Sentiment Rating	Positive News See Recent CRWD News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/23/2025	Roth Capital 2 of 5 stars	Taz Koujalgi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$410.00	+11.28%
4/16/2025	Morgan Stanley 3 of 5 stars	Hamza Fodderwala Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$429.00 ➝ $415.00	+6.39%
4/1/2025	Stephens 4 of 5 stars	Todd Weller Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$450.00	+27.09%
3/31/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joseph Gallo Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$425.00 ➝ $410.00	+16.78%
3/31/2025	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joel Fishbein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$460.00 ➝ $450.00	+26.01%
3/25/2025	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gray Powell Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$431.00	+15.66%
3/10/2025	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Cautious
3/5/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy
3/5/2025	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform
3/5/2025	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Set Target		$347.00	+11.43%
Get the Latest News and Ratings for CRWD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CrowdStrike and its competitors with MarketBeat's FREE daily newsletter.
3/5/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Fatima Boolani Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$450.00 ➝ $425.00	+16.30%
3/5/2025	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rudy Kessinger Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$395.00 ➝ $415.00	+17.03%
3/5/2025	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Ives Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$390.00 ➝ $395.00	+11.39%
3/5/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Ruykhaver Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$440.00 ➝ $440.00	+23.70%
3/5/2025	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Adam Borg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$475.00 ➝ $435.00	+22.11%
3/5/2025	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Eric Heath Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$480.00 ➝ $450.00	+26.32%
3/5/2025	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Peter Levine Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$400.00 ➝ $450.00	+28.32%
3/5/2025	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shyam Patil Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Positive ➝ Positive	$400.00 ➝ $425.00	+21.19%
3/5/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Nowinski Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$400.00 ➝ $430.00	+22.62%
3/5/2025	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	John Difucci Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
3/5/2025	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$506.00 ➝ $475.00	+31.81%
3/5/2025	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$380.00 ➝ $405.00	+3.80%
3/5/2025	Westpark Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Casey Ryan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
3/5/2025	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$420.00 ➝ $420.00	+7.65%
3/5/2025	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$450.00 ➝ $450.00	+15.34%
3/5/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Shrenik Kothari Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral ➝ Neutral	$440.00 ➝ $405.00	+3.80%
3/3/2025	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Walkley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$370.00 ➝ $420.00	+7.23%
2/28/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Brian Essex Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$418.00 ➝ $450.00	+16.64%
2/26/2025	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Tal Liani Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$400.00 ➝ $420.00	+10.60%
2/12/2025	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Gregg Moskowitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$385.00 ➝ $450.00	+4.25%
2/5/2025	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Sector Perform ➝ Sector Perform
2/5/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy
2/3/2025	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Kothari Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
11/27/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Bersey Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
11/27/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$365.00 ➝ $410.00	+18.30%
11/27/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$347.00	-4.75%
11/18/2024	CICC Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform	$295.00	-13.99%
11/4/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Market Outperform ➝ Market Outperform	$400.00 ➝ $400.00	+32.79%
10/8/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Degasperi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$285.00	-0.69%
9/5/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$334.00 ➝ $327.00	+26.10%
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the May 1st funding window clos
8/30/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$400.00 ➝ $325.00	+18.57%
8/29/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$400.00 ➝ $380.00	+37.32%
8/26/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$350.00 ➝ $275.00	+3.02%
7/18/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Sell	$380.00 ➝ $275.00	-22.52%
6/5/2024	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Seyrafi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
3/19/2024	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$370.00	+17.87%
10/18/2023	DZ Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$215.00	+14.89%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 03:06 AM ET.

Should I Buy CrowdStrike Stock? CRWD Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, April 22, 2025. Please send any questions or comments about these CrowdStrike pros and cons to contact@marketbeat.com.

CrowdStrike
Bull Case

Here are some ways that investors could benefit from investing in CrowdStrike Holdings, Inc.:

The current stock price is around $362, which is significantly lower than its one-year high of $455.59, potentially offering a buying opportunity for investors looking for value.
CrowdStrike Holdings, Inc. has received multiple "buy" ratings from analysts, indicating strong confidence in the company's growth potential and market position.
The company has a robust market capitalization of approximately $89.90 billion, suggesting a strong presence in the cybersecurity sector, which is increasingly important in today's digital landscape.
With a P/E ratio of 711.17, while high, it reflects the market's expectations for future growth, indicating that investors are willing to pay a premium for anticipated earnings.
Recent analyst reports have set a consensus price target of around $400.53, suggesting potential upside from the current trading price.

CrowdStrike
Bear Case

Investors should be bearish about investing in CrowdStrike Holdings, Inc. for these reasons:

The stock has experienced significant volatility, with a beta of 1.28, indicating that it is more volatile than the market, which could lead to higher risk for investors.
Insider selling has been notable, with directors selling a total of 119,401 shares recently, which may raise concerns about the company's future performance and insider confidence.
The company has a high P/E ratio, which could indicate that the stock is overvalued relative to its earnings, posing a risk if growth does not meet market expectations.
Despite a strong market presence, the company has received a mix of ratings, including "neutral" from some analysts, suggesting uncertainty about its future performance.
With a debt-to-equity ratio of 0.24, while relatively low, any increase in debt could impact financial stability and investor confidence in the long term.

CRWD Forecast - Frequently Asked Questions

: According to the research reports of 45 Wall Street equities research analysts, the average twelve-month stock price forecast for CrowdStrike is $400.76, with a high forecast of $475.00 and a low forecast of $275.00.
: 45 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CrowdStrike in the last twelve months. There are currently 2 sell ratings, 10 hold ratings, 30 buy ratings and 3 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CRWD shares.
: According to analysts, CrowdStrike's stock has a predicted downside of -9.04% based on their 12-month stock forecasts.
: Over the previous 90 days, CrowdStrike's stock had 3 upgrades and 2 downgrades by analysts.
: CrowdStrike has been rated by research analysts at Bank of America, Barclays, BMO Capital Markets, BTIG Research, Canaccord Genuity Group, Cantor Fitzgerald, Citigroup, DA Davidson, Evercore ISI, Guggenheim, Jefferies Financial Group, JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Needham & Company LLC, Piper Sandler, Raymond James, Robert W. Baird, Rosenblatt Securities, Roth Capital, Royal Bank of Canada, Scotiabank, Stephens, Stifel Nicolaus, Susquehanna, The Goldman Sachs Group, Truist Financial, UBS Group, Wedbush, Wells Fargo & Company, and Westpark Capital in the past 90 days.
: Analysts like CrowdStrike more than other "computer and technology" companies. The consensus rating score for CrowdStrike is 2.76 while the average consensus rating score for "computer and technology" companies is 2.66. Learn more on how CRWD compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NASDAQ:CRWD) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CrowdStrike (CRWD) Stock Forecast & Price Target